This project aims to determine the molecular genetic bases of the various forms of cogenital adrenal hyperplasia (CAH). CAH results from an inherited metabolic defect in cortisol biosynthesis. It may cause abnormalities in sexual differentiation, somatic growth, and salt metabolism. While any of the five metabolic steps in the pathway from cholesterol to cortisol may be affected, 95% of cases involve the 21-hydroxylation of 17-hydroxyprogesterone tp 11-deoxycortisol (21-hydroxylase deficiency), and in most of the remainder, 11B-hydroxylation is defective (11B-hydroxylase deficiency.) Both of these hydroxylation steps are mediated by specific adrenal cytochromes P-450 (respectively termed P-450 and P-450). The project therefore concentrates on the manner in which mutations in genes for these P-450 enzymes result in CAH. Previously, cDNA clones have been isolated which encode bovine and human P-450 as well as cosmid clones containing both normal P-450 genomic genes. One of these two genes may be a pseudogene, while many of the most severe cases of 21-OHase deficiency results from a deletion of the other, normally active gene. Milder forms of 21-OHase deficiency probably result from various point mutations. These genes are located in the HLA major histocompatibility complex, and different mutations appear to be associated with characteristic HLA antigens. Such mutations will be defined by producing genomic libraries using DNA from patients with 21-OHase deficiency who are homozygous for characeristic HLA antigens, and isolating and sequencing mutant genes. Previously isolated bovine cDNA clones encoding P-450 and P-450 (cholesterol side-chain cleavage enzyme) will be used to probe a human fetal adrenal cDNA library to identify the corresponding human genes, which will then be used to probe a genomic library to identify the genomic genes. The DNA sequences of these genes will be determined, and the chromosomal locations of these genes determined by in situ hybridization or hybridization to somatic cell hybrids. These studies should provide reagents which will be useful in haplotype identification for purposes of prenatal diagnosis of these defects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037867-03
Application #
3236823
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1986-02-15
Project End
1989-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Bassett, Mary H; Suzuki, Takashi; Sasano, Hironobu et al. (2004) The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 18:279-90
Bassett, Mary H; White, Perrin C; Rainey, William E (2004) The regulation of aldosterone synthase expression. Mol Cell Endocrinol 217:67-74
Pezzi, Vincenzo; Mathis, J M; Rainey, William E et al. (2003) Profiling transcript levels for steroidogenic enzymes in fetal tissues. J Steroid Biochem Mol Biol 87:181-9
Bassett, M H; Zhang, Y; Clyne, C et al. (2002) Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 28:125-35
Condon, Jennifer C; Pezzi, Vincenzo; Drummond, Brad M et al. (2002) Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143:3651-7
Wang, X L; Bassett, M; Zhang, Y et al. (2000) Transcriptional regulation of human 11beta-hydroxylase (hCYP11B1). Endocrinology 141:3587-94
Bassett, M H; Zhang, Y; White, P C et al. (2000) Regulation of human CYP11B2 and CYP11B1: comparing the role of the common CRE/Ad1 element. Endocr Res 26:941-51
Ylitalo, A; Airaksinen, K E; Hautanen, A et al. (2000) Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol 35:194-200
Hautanen, A; Toivanen, P; Manttari, M et al. (1999) Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation 100:2213-8
Kupari, M; Hautanen, A; Lankinen, L et al. (1998) Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97:569-75

Showing the most recent 10 out of 48 publications